FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

662711000001107: Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17125501000001115 Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
41170601000001111 Dipentum 500mg tablets (UCB Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) Is a Product containing precisely olsalazine sodium 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) Has active ingredient Olsalazine sodium false Inferred relationship Existential restriction modifier
Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) Is a Dipentum true Inferred relationship Existential restriction modifier
Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) Has specific active ingredient Olsalazine sodium true Inferred relationship Existential restriction modifier
Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) 60 tablet Is pack of False Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) 60 tablet Has AMP True Dipentum 500mg tablets (Celltech Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start